Abstract

BackgroundCurrently, there is an unwavering consensus that the standard surgery for congenital biliary dilation (CBD) is extrahepatic bile duct resection and choledochojejunostomy. However, decades prior, choledochocyst–gastrointestinal anastomosis without extrahepatic bile duct resection (internal drainage surgery, IDS) was preferred for CBD because of its simplicity. Currently, there is almost no chance of a surgeon encountering a patient who has undergone old-fashioned IDS, which has been completely obsolete due to the risk of carcinogenesis from the remaining bile duct. Moreover, the pathological condition long after IDS is unclear. Herein, we report a case of life-threatening bile duct bleeding as well as carcinoma of the bile duct 62 years after IDS in a patient with CBD.Case presentationAn 82-year-old Japanese woman with hemorrhagic shock due to gastrointestinal bleeding was transferred to our hospital. She had a medical history of unspecified surgery for CBD at the age of 20. Based on imaging findings and an understanding of the historical transition of the surgical procedure for CBD, the cause of gastrointestinal bleeding was determined to be rupture of the pseudoaneurysm of the dilated bile duct that remained after IDS. Hemostasis was successfully performed by transcatheter arterial embolization (TAE) in an emergency setting. Then, elective surgery for extrahepatic bile duct resection and choledochojejunostomy was performed to prevent rebleeding. Pathological examination revealed severely and chronically inflamed mucosa of the bile duct. Additionally, cholangiocarcinoma (Tis, N0, M0, pStage 0) was incidentally revealed.ConclusionIt has been indicated that not only carcinogenesis, but also a risk of life-threatening bleeding exists due to long-lasting chronic inflammation to the remnant bile duct after IDS for CBD. Additionally, both knowledge of which CBD operation was performed, and an accurate clinical history are important for the diagnosis of hemobilia.

Highlights

  • There is an unwavering consensus that the standard surgery for congenital biliary dilation (CBD) is extrahepatic bile duct resection and choledochojejunostomy

  • It has been indicated that carcinogenesis, and a risk of life-threatening bleeding exists due to long-lasting chronic inflammation to the remnant bile duct after IDS for CBD

  • Both knowledge of which CBD operation was performed, and an accurate clinical history are important for the diagnosis of hemobilia

Read more

Summary

Conclusion

We report a case of massive hemobilia in a patient with CBD who underwent IDS for CBD 62 years ago. A certain number of patients who have undergone IDS for CBD remain alive. When encountering hemobilia in the clinic, it is important to have an accurate medical history of the potential for CBD and any related surgical procedures. HT, MS, KW, KS and TM supervised the manuscript. All authors read and approved the final manuscript. Consent for publication Written informed consent was obtained from the patient for publication of this case report. Author details 1 Department of Surgery, Teikyo University School of Medicine, 2‐11‐1 Kaga, Itabashi‐Ku, Tokyo 173‐8606, Japan. 2 Department of Pathology, Teikyo University Hospital, 2‐11‐1 Kaga, Itabashi‐Ku, Tokyo 173‐8606, Japan

Background
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.